glp 1 vs bariatric surgery Metabolic and GLP-1 agonists | Blog Choosing Between Weight Loss Medications

When switching between GLP1RAs, transient GI AEs are expected and can be reduced by slow uptitration, including use of intermediary doses, and advising patients to reduce portion sizes and fat intake

(8) Excess body weight increases the mechanical load on weight-bearing joints, accelerating cartilage wear and joint degeneration, and contributing to a pro-inflammatory state that further exacerbates joint damage

Apovian said some people using compounded or counterfeit medications do not have obesity and may be using the drugs strictly to lose a few pounds

Under the brand name Zepbound, it's approved to treat obesity, while under the brand name Mounjaro, it's approved to treat type 2 diabetes

Patients who had success on compounded GLP-1s should talk with their primary care providers or obesity medicine specialists, says Dr